The United States’ reckoning with racism during the COVID-19 pandemic: What can we learn and do as allergist-immunologists? - 04/02/21
![](/templates/common/images/mail.png)
Key words : COVID-19, pandemic, disparities, asthma, racism, structural racism
Il testo completo di questo articolo è disponibile in PDF.
This study was conducted with support from the BWH H. Richard Nesson Fellowship (grant nos. K24 AI 106822 and U01 AI 110397) and NHLBI L30 HL143781. |
|
Disclosure of potential conflict of interest: L. S. Wright is US Medical Director, ImmunoDiagnostics-Clinical Affairs, ThermoFisher Scientific. W. Phipatanakul provided/received advisory/clinical trial support from Genentech/Novartis and Sanofi/Regeneron; provided advisory support to Teva and AstraZeneca; and received clinical trial support from GlaxoSmithKline, ThermoFisher, Monaghen, Alk Abello, Lincoln diagnostics, Circassia, Merck, and Kaleo. M. Louisias has no relevant conflicts of interest. |
Vol 147 - N° 2
P. 504-506 - Febbraio 2021 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.